Elisa Alchera Selected Research

Alcoholic Fatty Liver

9/2012

Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Alchera Research Topics

Disease

7	Neoplasms (Cancer) 01/2024 - 01/2017
7	Hypoxia (Hypoxemia) 11/2017 - 05/2006
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2020
3	Reperfusion Injury 11/2021 - 05/2009
3	Ischemia 03/2015 - 12/2010
3	Acidosis 07/2008 - 08/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2006
2	Inflammation (Inflammations) 09/2012 - 08/2007
1	Liver Diseases (Liver Disease) 11/2021
1	Fatty Liver 11/2021
1	Carcinogenesis 12/2020
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Necrosis 02/2016
1	Body Weight (Weight, Body) 09/2012
1	Alcoholic Fatty Liver 09/2012
1	Fibrosis (Cirrhosis) 09/2012
1	Chronic Hepatitis C 04/2007
1	Infections 04/2007
1	Lymphoma (Lymphomas) 01/2006
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2006
1	Cadaver (Cadavers) 01/2006

Drug/Important Bio-Agent (IBA)

6	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 11/2021 - 07/2008
4	GoldIBA 08/2023 - 11/2021
2	LigandsIBA 08/2023 - 02/2016
2	IntegrinsIBA 08/2023 - 12/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 08/2007
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2017 - 09/2012
2	Alanine Transaminase (SGPT)IBA 09/2012 - 04/2011
2	Adenosine (Adenocard)FDA LinkGeneric 07/2008 - 08/2007
2	Adenosine Triphosphate (ATP)IBA 04/2007 - 08/2006
2	AntibodiesIBA 04/2007 - 01/2006
1	pembrolizumabIBA 01/2024
1	Cyclic PeptidesIBA 08/2023
1	Contrast MediaIBA 08/2023
1	SodiumIBA 01/2023
1	Peptides (Polypeptides)IBA 12/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 11/2017
1	ChemokinesIBA 01/2017
1	CytokinesIBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	CC ChemokinesIBA 02/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2016
1	Pyruvate KinaseIBA 03/2015
1	ArginaseIBA 03/2015
1	ProteomeIBA 03/2015
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	Nonesterified Fatty Acids (NEFA)IBA 09/2012
1	Acetazolamide (Diamox)FDA LinkGeneric 07/2008
1	Bicarbonates (Hydrogen Carbonate)IBA 07/2008
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 08/2007
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 08/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2007
1	p38 Mitogen-Activated Protein KinasesIBA 04/2007
1	CytochromesIBA 04/2007
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 04/2007
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 04/2007
1	adenosine 5'-O-(3-thiotriphosphate)IBA 08/2006
1	adenosine 5'-O-(2-thiodiphosphate) (ADP-S)IBA 08/2006
1	PD 98058IBA 08/2006
1	Purinergic P2Y2 ReceptorsIBA 08/2006
1	Purinergic AgonistsIBA 08/2006
1	Uridine Triphosphate (UTP)IBA 08/2006
1	NOC 9IBA 05/2006
1	WortmanninIBA 05/2006
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2006
1	AntigensIBA 01/2006
1	Monoclonal AntibodiesIBA 01/2006
1	Ethanol (Ethyl Alcohol)IBA 01/2006
1	PhosphatidylserinesIBA 01/2006

Therapy/Procedure

2	Photothermal Therapy 03/2023 - 11/2021
2	Therapeutics 01/2023 - 12/2020
2	Transplantation 11/2021 - 04/2011
2	Liver Transplantation 12/2010 - 05/2009
1	Immunotherapy 01/2024
1	Intravesical Administration 08/2023
1	Lasers (Laser) 11/2021
1	Ligation 01/2006